Abiopharma

Xenon to Highlight Phase 3 X-TOLE2 & Long-Term Data for Azetukalner in Focal Onset Seizures at 2026 AAN Annual Meeting

Gilead to Acquire Tubulis Adding Potentially Best-in-Class Antibody-Drug Conjugate and Next Generation Platform to Further Strengthen Oncology Pipeline

Jaguar Health Reports 2025 Financials

New Form 424B2 - ROYAL BANK OF CANADA <b>Filed:</b> 2026-04-07 <b>AccNo:</b> 0000950103-26-005415 <b>Size:</b> 256 KB

New Form 424B2 - TORONTO DOMINION BANK <b>Filed:</b> 2026-04-07 <b>AccNo:</b> 0001140361-26-013584 <b>Size:</b> 560 KB

HALEON PLC (HLN) Files Form 6-K

New Form FWP - JPMORGAN CHASE & CO <b>Filed:</b> 2026-04-07 <b>AccNo:</b> 0001213900-26-040816 <b>Size:</b> 6 MB

New Form SCHEDULE 13G - XFLH Capital Corp <b>Filed:</b> 2026-04-07 <b>AccNo:</b> 0001172661-26-001385 <b>Size:</b> 8 KB

New Form 424B2 - ROYAL BANK OF CANADA <b>Filed:</b> 2026-04-07 <b>AccNo:</b> 0000950103-26-005414 <b>Size:</b> 152 KB

Bharucha Kaizad 🟡 adjusted position in 0 shares (1 derivative) of HDFC BANK LTD (HDB) at $6.80 Transaction Date: Apr 03, 2026 | Filing ID: 000006

Shah Nirav Vimal 🟡 adjusted position in 0 shares (1 derivative) of HDFC BANK LTD (HDB) at $6.80 Transaction Date: Apr 02, 2026 | Filing ID: 000004

GSK PLC (GSK) Files Form 6-K

New Form FWP - JPMORGAN CHASE & CO <b>Filed:</b> 2026-04-07 <b>AccNo:</b> 0001213900-26-040809 <b>Size:</b> 2 MB

New Form FWP - JPMORGAN CHASE & CO <b>Filed:</b> 2026-04-07 <b>AccNo:</b> 0001213900-26-040807 <b>Size:</b> 2 MB

enGene Announces Name Change to enGene Therapeutics Inc.